Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors.

ACG Case Rep J

West Palm Beach VA Medical Center, Division of Gastroenterology and Hepatology, West Palm Beach, FL.

Published: January 2021

Empagliflozin belongs to a class of sodium-glucose cotransporter-2 inhibitors, a medication approved by the US Food and Drug Administration in 2014 for the treatment of type 2 diabetes mellitus. Well-known side effects of this medication include symptomatic hypotension, hypoglycemia, and urinary tract infections among others. We present a case of severe epigastric abdominal pain consistent with acute pancreatitis in the setting of empagliflozin use, suggesting a possible drug-induced acute pancreatitis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813547PMC
http://dx.doi.org/10.14309/crj.0000000000000530DOI Listing

Publication Analysis

Top Keywords

acute pancreatitis
8
empagliflozin-associated pancreatitis
4
pancreatitis consideration
4
consideration sglt2
4
sglt2 inhibitors
4
inhibitors empagliflozin
4
empagliflozin belongs
4
belongs class
4
class sodium-glucose
4
sodium-glucose cotransporter-2
4

Similar Publications

Objectives: Endoscopic ultrasonography (EUS)-guided radiofrequency ablation has recently been introduced as one of the management strategies for small pancreatic neuroendocrine neoplasms (PNENs). However, prospective data on its safety and efficacy remain limited.

Methods: This prospective pilot study was conducted at Okayama University Hospital from May 2023 to December 2024.

View Article and Find Full Text PDF

Objectives: Central nervous system complications of acute pancreatitis (AP) can result in cerebral edema (CE). We assessed the risk of serious outcomes and health care features associated with CE in patients hospitalized with AP.

Methods: We conducted a retrospective cohort study using the National Inpatient Sample database.

View Article and Find Full Text PDF

Groove pancreatitis (GP) is a chronic segmental pancreatitis which leads to altered pancreatic secretions and pancreatitis. The exact pathogenesis of GP has not been clearly identified to date but heavy smoking and chronic alcohol consumption seem to be the main factors involved. The resulting chronic pancreatitis (CP) is a debilitating disease causing abdominal pain often refractory to medical therapy, so much that the main indication for surgical treatment is intractable abdominal pain.

View Article and Find Full Text PDF

Purpose: Metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic fatty pancreatic disease (NAFPD) are metabolic diseases with rising incidence. Fatty infiltration may lead to dysfunction of the liver and pancreatic tissues. This study aims to quantify liver and pancreatic fat fractions and examine their correlation with disease severity in acute pancreatitis patients.

View Article and Find Full Text PDF

Objectives: Traditional scoring systems have been widely used to predict acute pancreatitis (AP) severity but have limitations in predictive accuracy. This study investigates the use of machine learning (ML) algorithms to improve predictive accuracy in AP.

Methods: A retrospective study was conducted using data from 101 AP patients in a tertiary hospital in Türkiye.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!